Casdin Partners Master Fund, L.P. bought LAB
August 22, 2025 · Form 4 insider transaction
Casdin Partners Master Fund, L.P. bought 200,000 shares of Standard BioTools Inc. at $1.26 per share, a transaction worth $252.7K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
200,000
Price
$1.26
Total value
$252.7K
Role—
CompanyStandard BioTools Inc. (LAB)
SecurityCommon Stock, $0.001 par value per share
Transaction codeP: Open-market purchase
Transaction dateAugust 22, 2025
Filing dateAugust 26, 2025
Shares owned after59,950,000
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
The securities are owned directly by Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC ("Casdin"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (the "GP"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin and the GP.